SmartestCrowd
Organizations
Orgs
No organizations
Projects
No projects
0
0
Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma | NEJM - nejm.org
10/21/23 at 12:45pm
Organization
nejm.org
Author
nejm.org
13 words
0
Comments
Business & Industrial
Tebentafusp
Metastatic Uveal Melanoma
You are the first to view
https://www.nejm.org/doi/pdf/10.1056/NEJMoa2304753
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...